About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Long-term Study of DSP-5423P in Patients With Schizophrenia

Long-term Study of DSP-5423P in Patients With Schizophrenia

NCT02335658·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sumitomo Pharma Co., Ltd.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients who have schizophrenia diagnosed by DSM-5, diagnostic criteria
Patients who are aged 18 years or older at informed consent
Patient understands the objectives and procedures of the study and who provide written voluntarily consent to participate in the study, etc.

You may not be if

Patients who fall under a contraindication listed in the LONASEN® package insert
Patients with Parkinson disease, etc.

The record

StatusCompleted

PhasePhase 3

Taking part200

StartedDec 2014

UpdatedApr 12, 2022

Conditions

Where1

38 Sites
Tokyo, Japan